News - Event

      November 18, 2021 Event

      Oblique will be at the 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit

      February 22- 24, 2022 Boston MA

      Read more

      October 14, 2021 Event

      Oblique Therapeutics presents its anti-Thioredoxin mAb program

      at the annual meeting of Society for Immunotherapy of Cancer, Nov 10 – 14, Washington DC, USA.

      Read more

      September 3, 2021 Event

      Have you missed Obliques’ presentation

      during the Pareto Securities’ Healthcare Conference 2021?

      Read more

      August 30, 2021 Event

      For the 1st Neuropathic Pain Therapeutics Summit

      our Head of Discovery & Preclinical R&D- Ion Channel Target in Pain – Daniela Papadia was invited as Expert Speaker.

      Read more

      March 11, 2021 Event

      On March 10th 2021, Professor Owe Orwar, CEO

      presented Oblique Therapeutics AB at Carnegie Nordic Virtual Healthcare Seminar 2021.

      Read more

      September 21, 2020 Event

      24th Sept 2020 – Oblique Therapeutics

      is delighted to be invited to speak at “Biopharma Conclave 2020”.

      Read more

      September 14, 2020 Event

      Oblique Therapeutics is honored to participate

      as speaker to the 2nd Edition RAS-Targeted Drug Development Congress 15th September 2020.

      Read more

      October 24, 2019 Event

      Oblique will be presenting at the RAS-Targeted

      Drug Discovery Europe Summit in February.

      Read more